HLS Therapeutics, Inc. (HLS.TO)
4.33
+0.18
(+4.34%)
CAD |
TSX |
Oct 23, 16:00
HLS Therapeutics Max Drawdown (5Y) : 87.57% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 87.57% |
| August 31, 2026 | 87.57% |
| July 31, 2026 | 87.57% |
| June 30, 2026 | 87.57% |
| May 31, 2026 | 87.57% |
| April 30, 2026 | 87.57% |
| March 31, 2026 | 87.57% |
| February 28, 2026 | 87.57% |
| January 31, 2026 | 87.57% |
| December 31, 2025 | 87.57% |
| November 30, 2025 | 87.57% |
| October 31, 2025 | 87.57% |
| September 30, 2025 | 87.57% |
| August 31, 2025 | 87.57% |
| July 31, 2025 | 87.57% |
| June 30, 2025 | 87.57% |
| May 31, 2025 | 87.57% |
| April 30, 2025 | 87.57% |
| March 31, 2025 | 87.57% |
| February 28, 2025 | 87.57% |
| January 31, 2025 | 87.57% |
| December 31, 2024 | 87.57% |
| November 30, 2024 | 87.57% |
| October 31, 2024 | 87.57% |
| September 30, 2024 | 87.57% |
| Date | Value |
|---|---|
| August 31, 2024 | 87.57% |
| July 31, 2024 | 87.03% |
| June 30, 2024 | 86.37% |
| May 31, 2024 | 86.12% |
| April 30, 2024 | 86.12% |
| March 31, 2024 | 86.12% |
| February 29, 2024 | 86.12% |
| January 31, 2024 | 86.12% |
| December 31, 2023 | 86.12% |
| November 30, 2023 | 86.12% |
| October 31, 2023 | 82.86% |
| September 30, 2023 | 82.86% |
| August 31, 2023 | 82.86% |
| July 31, 2023 | 82.86% |
| June 30, 2023 | 82.86% |
| May 31, 2023 | 82.86% |
| April 30, 2023 | 76.87% |
| March 31, 2023 | 75.22% |
| February 28, 2023 | 65.77% |
| January 31, 2023 | 65.77% |
| December 31, 2022 | 65.77% |
| November 30, 2022 | 65.77% |
| October 31, 2022 | 64.61% |
| September 30, 2022 | 64.61% |
| August 31, 2022 | 54.53% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Bausch Health Cos., Inc. | 87.23% |
| Cipher Pharmaceuticals, Inc. | 72.28% |
| BioSyent, Inc. | 37.15% |
| Revive Therapeutics Ltd. | 99.36% |
| Knight Therapeutics, Inc. | 52.84% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.53 |
| Beta (5Y) | 0.7747 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.47% |
| Historical Sharpe Ratio (5Y) | -0.6805 |
| Historical Sortino (5Y) | -1.023 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.88% |